Table 3.

Adjusted full model

Variables	Description	Full model
		−2LL: 2774, adj. r 2 : 0.26			N
					2441
		OR	95%-CI
Gender	male vs female	1.57	1.29	1.91
Age	11-19 vs 20–29 yrs	1.06	0.75	1.49
	30-39 vs 20–29 yrs	1.80	1.35	2.40
	40-44 vs 20–29 yrs	2.64	1.96	3.56
	45-49 vs 20–29 yrs	3.49	2.59	4.71
	50-54 vs 20–29 yrs	4.53	2.84	7.23
	55 and older vs 20–29 yrs	91.61	12.12	692.24
BMI	0-19 vs 20-24	1.12	0.75	1.66
	25-29 vs 20-24	1.98	1.60	2.44
	30 and more vs 20-24	3.13	1.32	7.39
ICU stay	3-7 vs 0–2 days	1.48	1.21	1.82
	8-11 vs 0–2 days	2.69	1.96	3.69
	12-15 vs 0–2 days	4.96	2.94	8.37
	16 and longer vs 0–2 days	4.85	2.41	9.78
History of smoking	Smoking Yes vs No	1.32	1.10	1.60
Cause of brain death	traumatic brain death No vs Yes	1.28	1.04	1.58
Sodium	Sodium <120 vs 135-145	2.17	0.26	23.97
	Sodium 120–134 vs 135-145	0.97	0.66	1.42
	Sodium 146–159 vs 135-145	1.14	0.94	1.39
	Sodium 160 < vs 135-145	1.75	1.18	2.61
Serum blood glucose	Glucose <100 vs 100-130	1.23	0.93	1.62
	Glucose 131–180 vs 100-130	1.18	0.95	1.47
	Glucose 181–209 vs 100-130	0.90	0.61	1.31
	Glucose 210 < vs 100-130	1.76	1.21	2.58
Lipase/Amylase	if at least one value was given**
	elevated vs low	1.39	1.03	1.87
	highly elevated vs low	2.06	1.27	3.33
Virology	min. 1 positive virol. Statement	removed/backward-selection
Catecholamine	administration Yes vs No	removed/backward-selection
Status of liver	Liver not reported vs liver reported	4.95	1.01	24.13

**Amylase categorized as low (<130), elevated (130–389) and highly elevated (≥390); Lipase categorized as low (<160), elevated (160–479) and highly elevated (≥480); the categories were chosen if either one of the enzymes scored elevated/highly elevated.